A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus

Journal of Immunology

Volumn 160, Issue 5, 1998, Pages 2365-2373

  Ettinger, Ruth A ^a   Kwok, William W ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INSULIN BINDING; INSULIN DEPENDENT DIABETES MELLITUS; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

ALLELES; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BINDING SITES; DIABETES MELLITUS, TYPE 1; GENES, DOMINANT; HLA-DQ ANTIGENS; HUMANS; INSULIN; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING;

EID: 0032030625     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Todd, J. A., and M. Farrall. 1996. Panning for gold: genome-wide scanning for linkage in type I diabetes. Hum. Mol. Genet. 5:1443.
2. Reijonen, H., and G. T. Nepom. 1997. Role of HLA susceptibility in predisposing to insulin-dependent diabetes mellitus. In Frontiers in Hormone Research. Vol. 22: Molecular Pathogenesis of Diabetes Mellitus, R. D. G. Leslie, ed. Basel, S. Karger AG, p. 46.
3. Ronningen, K. S., A. Spurkland, B. D. Tait, B. Drummond, C. Lopez-Larrea, F. S. Baranda, M. J. Menendez-Diaz, S. Caillat-Zucman, G. Beaurain, H.-J. Garchon, J. Ilonen, H. Reijonen, M. Knip, B. O. Boehm, C. Rosak, C. Löliger, P. Kuhnl, T. Ottenhoff, L. Contu, C. Carcassi, M. Savi, P. Zanelli, T. M. Neri, K. Hamaguchi, A. Kimura, R. P. Dong, N. Chikuba, S. Nagataki, C. Gorodezky, H. Debaz, C. Robles, H. B. Coimbra, A. Martinho, M. A. Ruas, J. A. Sachs, M. Garcia-Pachedo, A. Biro, A. Nikaein, L. Dombrausky, T. Gonwa, C. Zmijewski, D. Monos, M. Kamoun, Z. Layrisse, M. C. Magli, P. Balducci, and E. Thorsby. 1992. HLA elass II associations in insulin-dependent diabetes mellitus among Blacks. Caucasoids, and Japanese. In HLA 1991. K. Tsuji, M. Aizawa, and T. Sasazuki, eds. Oxford University Press, New York, p. 713.
4. Baisch, J. M., T. Weeks, R. Giles, M. Hoover, P. Stastny, and J. D. Capra. 1990. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N. Engl. J. Med. 322:1836.
5. Zeliszewski, D., J.-M. Tiercy, C. Boitard, X.-F. Gu, M. Loche, R. Krishnamoorthy, N. Simonney, J. Elion, J.-F. Bach, B. Mach, and G. Sterkers. 1992. Extensive study of DRB, DQA, and DQB gene polymorphism in 23 DR2-positive, insulin-dependent diabetes mellitus patients. Hum. Immunol. 33:140.
6. Reijonen, H., J. Ilonen, H. K. Åkerblom, M. Knip, and H.-M. Dosch. 1994. Multi-locus analysis of HLA class II genes in DR2-positive IDDM haplotypes in Finland. Tissue Antigens 43:1.
7. Sanjeevi, C. B., T. P. Lybrand, M. Landin-Olsson, I. Kockum, G. Dahlquist, W. A. Hagopian, J. P. Palmer, and Å. Lemmark. 1994. Analysis of antibody markers. DRB1, DRB5, DQA1, and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus. Tissue Antigens 44:110.
8. Rammensee, H.-G., T. Friede, and S. Stevanović. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
9. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215.
10. Ghosh, P., M. Amaya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 178:457.
11. Sette, A., J. Sidney, C. Oseroff, M.-F. del Guercio, S. Southwood, T. Arrhenius, M. F. Powell, S. M. Colon, F. C. A. Gaeta, and H. M. Grey. 1993. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immunol. 151:3163.
12. Hammer, J., F. Gallazzi, E. Bono, R. W. Karr, J. Guenot, P. Valsasnini, Z. A. Nagy, and F. Sinigaglia. 1995. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 181: 1847.
13. Matsushita, S., K. Takahashi, M. Motoki, K. Komoriya, S. Ikagawa, and Y. Nishimura. 1994. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J. Exp. Med. 180:873.
14. Geluk, A., K. E. van Meijgaarden, S. Southwood, C. Oseroff, J. Wouter Drijfhout, R. R. P. de Vries, T. H. M. Ottenhoff, and A. Seite. 1994. HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs. J. Immunol. 152: 5742.
15. Kwok, W. W., M. E. Domeier, F. C. Raymond, P. Byers, and G. T. Nepom. 1996. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156:2171.
16. Johansen, B. H., F. Vartdal, J. A. Eriksen, E. Thorsby, and L. M. Sollid. 1996. Identification of a putative motif for binding of peptides to HLA-DQ2. Int. Immunol. 8:177.
17. van de Wal, Y., Y. M. C. Kooy, J. W. Drijfhout, R. Amons, and F. Koning. 1996. Peptide binding characteristics of the coeliac disease-associated DQ(α1*0501, β1*0201) molecule. Immunogenetics 44:246.
18. Wucherpfennig, K. W., A. Sette, S. Southwood, C. Oseroff, M. Matsui, J. L. Strominger, and D. A. Hafler. 1994. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and its recognition by human T cell clones. J. Exp. Med. 179:279.
19. Vogt, A. B., H. Kropshofer, H. Kalbacher, M. Kalbus, H.-G. Rammensee, J. E. Coligan, and R. Martin. 1994. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J. Immunol. 153:1665.
20. Christie, M. R. 1996. Islet cell autoantigens in type I diabetes. Eur. J. Clin. Invest. 26:827.
21. Vafiadis, P., S. T. Bennett, J. A. Todd, J. Nadeau, R. Grabs, C. G. Goodyer, S. Wickramasinghe, E. Colle, and C. Polychronakos. 1997. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet. 15:289.
22. Pugliese, A., M. Zeller, A. Fernandez., Jr., L. J. Zalcberg, R. J. Bartlett, C. Ricordi, M. Pietropaolo, G. S. Eisenbarth, S. T. Bennett, and D. D. Patel. 1997. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 15:293.
23. French, M. B., J. Allison, D. S. Cram, H. E. Thomas, M. Dempsey-Collier, A. Silva, H. M. Georgiou, T. W. Kay, L. C. Harrison, and A. M. Lew. 1997. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 46:34.
24. Kuglin, B., H. Kolb, C. Greenbaum, N. K. Maclaren, Å. Lernmark, and J. P. Palmer. 1990. The Fourth International Workshop on the Standardisation of Insulin Autoantibody. Diabetologia 33:638.
25. Bohmer, K., H. Keilacker, B. Kuglin, A. Hubinger, J. Bertrams, F. A. Gries, and H. Kolb. 1991. Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies. Diabetologia 34:830.
26. Roep, B. O. 1996. T-cell responses to autoantigens in IDDM. Diabetes 45:1147.
27. Rudy, G., N. Stone, L. C. Harrison, P. G. Colman, P. McNair, V. Brusic, M. B. French, M. C. Honeyman, B. Tait, and A. M. Lew. 1995. Similar peptides from two β cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol. Med. 1:625.
28. Wegmann, D. R., M. Norbury-Glaser, and D. Daniel. 1994. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol. 24:1853.
29. Daniel, D., R. G. Gill, N. Schloot, and D. Wegmann. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25:1056.
30. Daniel, D., and D. R. Wegmann. 1996. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. USA 93:956.
31. Kimura, A., R.-P. Dong, H. Harada, and T. Sasazuki. 1992. DNA typing of HLA class II genes in B-lymphoblastoid cell lines homozygous for HLA. Tissue Antigens 40:5.
32. Hume, C. R., L. A. Shookster, N. Collins, R. O'Reilly, J. S. Lee. 1989. Bare lymphocyte syndrome: altered HLA class II expression in B cell lines derived from two patients. Hum. Immunol. 25:1.
33. Kwok, W. W., G. T. Nepom, and F. C. Raymond. 1995. HLA-DQ polymorphisms are highly selective for peptide binding interactions. J. Immunol. 155: 2468.
34. Buus, S., A. Sette, S. M. Colon, D. M. Jenis, and H. M. Grey. 1986. Isolation and characterization of antigen-Ia complexes involved in T cell recognition. Cell 47:1071.
35. Roche, P. A., and Cresswell, P. 1990. High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR. J. Immunol. 144:1849.
36. Jensen, P. E. 1991. Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH. J. Exp. Med. 174:1111.
37. Johansen, B. H., S. Buus, F. Vandal, H. Viken, J. A. Eriksen, E. Thorsby, and L. M. Sollid. 1994. Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(α1*0501, β1*0201) molecule. Int. Immunol. 6:453.
38. Raddrizzani, L., T. Sturniolo, J. Guenot, E. Bono, F. Gallazzi, Z. A. Nagy, F. Sinigaglia, and J. Hammer. 1997. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires. J. Immunol. 159:703.
39. Creighton, T. E. 1984. Chemical nature of polypeptides. In Proteins Structures and Molecular Principles. W. H. Freeman and Co., New York, p. 1.
40. Karlsen, A. E., W. A. Hagopian, C. E. Grubin, S. Dube, C. M. Disteche, D. A. Adler, H. Bärmeier, S. Mathewes, F. J. Grant, D. Foster, and Å. Lemmark. 1991. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc. Natl. Acad. Sci. USA 88:8337.
41. Lan, M. S., J. Lu, Y. Goto, and A. L. Notkins. 1994. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol. 13:505.
42. Sures, I., D. V. Goeddel, A. Gray, and A. Ullrich. 1980. Nucleotide sequence of human preproinsulin complementary DNA. Science 208:57.
43. Kaufman, D. L., M. Clare-Salzler, J. Tian, T. Forsthuber, G. S. P. Ting, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin, and P. V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69.
44. Johansen, B. H., T. Gedde-Dahl III, L. M. Sollid, F. Vandal, E. Thorsby, and G. Gaudernack. 1994. Binding of rus oncogene peptides to purified HLA-DQ(α1*0102,β1*0602) and -DR(α,β1*0101) molecules. Scand. J. Immunol. 39: 607.
45. Tompkins, S. M., J. C. Moore, and P. E. Jensen. 1996. An insulin peptide that binds an alternative site in class II major histocompatibility complex. J. Exp. Med. 183:857.
46. Hammer, J., P. Valsasnini, K. Tolba, D. Bolin, J. Higelin, B. Takacs, and F. Sinigaglia. 1993. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74:197.
47. Kwok, W. W., M. E. Domeier, M. L. Johnson, G. T. Nepom, and D. M. Koelle. 1996. HLA-DQB1 codon 57 is critical for peptide binding and recognition. J. Exp. Med. 183:1253.
48. Nepom, B. S., G. T. Nepom, M. Coleman, and W. W. Kwok. 1996. Critical contribution of β chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc. Natl. Acad. Sci. USA 93:7202.
49. + first degree relatives of patients with type I diabetes expressing the HLA DQB1*0602 allele. J. Autoimmun. 9:423.
50. Ito, Y., M. Nieda, Y. Uchigata, M. Nishimura, K. Tokunaga, S. Kuwata, F. Obata, K. Tadokoro, Y. Hirata, Y. Omori, and T. Juji. 1993. Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J. Immunol. 151:5770.
51. Jensen, P. E. 1991. Reduction of disulfide bonds during antigen processing: evidence from a thiol-dependent insulin determinant. J. Exp. Med. 174:1121.
52. d molecules. J. Immunol. 151:3627.